Pancreatic Cancer Research

ResearcherHumanitas UniversityActive in the last 2 years

Viktor Hlaváč

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0695-0552; OpenAlex author ID A5064368523. Sources: OpenAlex.

Their work

Papers
20 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 6 papers · 2022: 1 paper · 2023: 3 papers · 2024: 2 papers · 2025: 3 papers

Papers 20

  1. Potential for Clinical Management of Pancreatic Cancer Through Whole Exome Profiling of Site-Specific Metastases and Matched Primary Tumors. Co-author DOI 10.1016/j.labinv.2025.104205↗
  2. Therapeutic pancreatic cancer biomarkers and pharmacogenetics. Co-author DOI 10.1016/j.semcancer.2025.08.002↗
  3. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  4. Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk. Co-author DOI 10.1002/ijc.35046↗
  5. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. Co-author DOI 10.1186/s40246-024-00576-x↗
  6. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  7. Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2022-108910↗
  8. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  9. Laser Capture Microdissection: A Gear for Pancreatic Cancer Research. Last author DOI 10.3390/ijms232314566↗
  10. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
  11. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/carcin/bgab057↗
  12. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. Co-author DOI 10.1136/jmedgenet-2020-106961↗
  13. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0353↗
  14. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  15. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. Co-author DOI 10.3389/fonc.2021.771312↗
  16. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
  17. KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanes. Co-author DOI 10.1093/mutage/gez021↗
  18. Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alteration… Co-author DOI 10.2147/cmar.s185352↗
  19. Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome. Co-author DOI 10.3892/ol.2017.6946↗
  20. The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer. Co-author DOI 10.1007/s00280-013-2246-2↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pavel Souček · 7 shared papers, 2013–2025 · strength 0.98
  2. Beatrice Mohelníková-Duchoňová · 6 shared papers, 2013–2025 · strength 0.71
  3. Aleš Langer · 2 shared papers, 2025 · strength 0.46
  4. Martin Loveček · 3 shared papers, 2017–2025 · strength 0.35
  5. Bhavana Hemantha Rao · 1 shared paper, 2022 · strength 0.26
  6. Ștefania Bunduc · 1 shared paper, 2025 · strength 0.24
  7. Michal Kroupa · 1 shared paper, 2025 · strength 0.24
  8. Riccardo Farinella · 1 shared paper, 2025 · strength 0.24
  9. Daniele Campa · 1 shared paper, 2025 · strength 0.24
  10. Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.24
  11. Lenka Červenková · 1 shared paper, 2025 · strength 0.22
  12. Martin Oliverius · 3 shared papers, 2013–2019 · strength 0.18
  13. Bohuslav Melichar · 3 shared papers, 2013–2019 · strength 0.16
  14. R Havlík · 2 shared papers, 2017–2019 · strength 0.13
  15. Jan Hlavsa · 2 shared papers, 2013–2017 · strength 0.09
  16. Zdeněk Kala · 2 shared papers, 2013–2017 · strength 0.09
  17. Marianna Borecká · 1 shared paper, 2019 · strength 0.08
  18. Č Neoral · 1 shared paper, 2019 · strength 0.08
  19. Tomáš Zemánek · 1 shared paper, 2019 · strength 0.08
  20. Zdeněk Kleibl · 1 shared paper, 2019 · strength 0.08
  21. Markéta Janatová · 1 shared paper, 2019 · strength 0.08
  22. Radmila Lemstrová · 1 shared paper, 2017 · strength 0.05
  23. David J. Hughes · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.